Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Cancer Cytopathol. 2021 Nov 30;130(4):284–293. doi: 10.1002/cncy.22537

TABLE 5.

Correlation of Molecular Alterations Between Cases With Malignant and Benign Histology

Molecular Alteration Malignant Histology, No. Benign Histology, No. Risk of Malignancy, % OR P
NRAS alone 3 17 15 0.166 .0322
NRAS with others 9 8 53
HRAS alone 3 8 27 0.88 .63
HRAS with others 3 7 30
KRAS alone 1 6 14 0.44 .5
KRAS with others 2 5 29
RAS mutation (overall) 21 51 29
RAS mutation (alone) 7 31 18 0.33 .031
RAS with others 14 20 41

Abbreviation: OR, odds ratio.